Home › Funds › Vestal Point Capital, LP › BBIO

Vestal Point Capital, LP position in BBIO

BRIDGEBIO PHARMA INC · Health Care

Vestal Point Capital, LP reported holding 400,000 shares of BBIO (BRIDGEBIO PHARMA INC) in its Q3 2026 13F filing — a position valued at US$26.3M, representing 0.68% of its reported portfolio and ranking #25 among its reported holdings. Vestal Point Capital, LP first reported this position in Q3 2026.

Latest position (Q3 2026)400.00K sh
Reported value held$26.32M
Portfolio Weight0.68%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's BBIO position evolved

Vestal Point Capital, LP first disclosed a stake in BBIO in Q3 2026 at 400,000 shares (US$26.3M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 400.00K $26.32M New

About BBIO and 13F data

BBIO (BRIDGEBIO PHARMA INC) is a Health Care company. 40 other funds we track also report a position in BBIO — the largest reported positions include Jupiter Topco LLC (US$1.05B), Janus Henderson Group (US$957.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$937.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBIO

All BBIO fund holders →

FAQ

How long has Vestal Point Capital, LP held BBIO?

Vestal Point Capital, LP has disclosed BBIO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Vestal Point Capital, LP's current position in BBIO?

As of Q3 2026, Vestal Point Capital, LP holds 400.00K shares of BBIO (BRIDGEBIO PHARMA INC), valued at $26.32M, representing 0.68% of its reported portfolio and ranking #25.

Has Vestal Point Capital, LP been buying or selling BBIO?

In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in BBIO.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, Janus Henderson Group, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.